Mission of Infla-Med

The Infla-Med Research Consortium of Excellence conducts fundamental research to pathophysiological processes of inflammatory diseases by using a multidisciplinary approach.

The members of the Infla-Med consortium will exchange (i) their expertise regarding design and synthesis of chemical tool compounds for target identification, characterization and inhibition; (ii) their platforms for in vitro and in vivo testing; (iii) a series of animal models to obtain new insights regarding inflammatory diseases which are of importance for clinical research.

The inflammatory diseases studied within Infla-Med are both infectious and non-infectious pathologies:

  • myocard ischemia and – reperfusion
  • acute and chronic heart failure
  • intima- and media calcifications
  • acute and chronic renal failure
  • inflammatory bowel diseases (IBD) and post-inflammatory irritable bowel syndrome (PI-IBS)
  • Helicobacter gastritis
  • Respiratory Syncytial Virus (RSV) infection
  • biofilms of both bacteria and yeast cells
  • intracellular parasitic infections